Acepromazinebldmcnc
Acepromazine blood test measures the concentration of acepromazine, a sedative medication, in your blood to ensure proper dosing and monitor drug levels.
{"Measures acepromazine levels in whole blood sample","Used to monitor therapeutic drug levels and prevent toxicity","Sample collected via blood draw from a vein","Results help healthcare providers adjust medication dosage","Important for patients on long-term acepromazine therapy"}
Key facts at a glance
- LOINC
- 60043-7
- Short code
- ACEPRZ
- Synonyms
- Acepromazine Bld-mCnc
- Category
- chemistry
- Sample
- whole-blood
- Container
- Purple-top EDTA tube (K2-EDTA)
- Units
- N/A
- Ref low
- 10
- Ref high
- 50
- Critical range
- — – 100 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
- CPT
- 80307
- SNOMED
- 372729004
- Specimen volume
- 2-3 mL whole blood
- Stability
- Room temperature: 7 days; Refrigerated (2-8°C): 14 days; Frozen (-20°C): 30 days. Protect from light.
- Hemolysis max
- 50
- Lipemia max
- 100
- Icterus max
- 20
- TAT
- 24–72 hours
- Order
- routine
What is this test?
The Acepromazine Blood Test measures the amount of acepromazine, a phenothiazine-derived tranquilizer and antiemetic medication, present in your whole blood. Acepromazine is commonly used as a sedative and is often prescribed for anxiety, motion sickness, and pre-procedural sedation. This test helps healthcare providers determine if the drug concentration is within the therapeutic range.
Why is this test performed?
This test is typically ordered to monitor patients who are receiving acepromazine therapy. It helps ensure that drug levels are within the therapeutic range—sufficient to provide the desired effect without reaching toxic levels. Regular monitoring is especially important for patients on long-term treatment, those with kidney or liver conditions that may affect drug metabolism, or when starting other medications that could interact with acepromazine.
How is the test done?
A healthcare professional will draw a blood sample from a vein in your arm using a small needle. The sample is then placed in a special tube and sent to a laboratory for analysis. The procedure typically takes only a few minutes and is generally well-tolerated with minimal discomfort.
How to prepare for the test
Follow your healthcare provider's instructions regarding medication timing. Do not stop taking acepromazine unless specifically instructed to do so. Inform your provider about all medications, supplements, and herbal products you are currently taking, as some substances may affect test results. Fasting is usually not required for this test.
Reference range
Therapeutic range: 10-50 ng/mL; Subtherapeutic: <10 ng/mL; Supratherapeutic: >50 ng/mLN/A
No specific patient preparation required. Collect whole blood specimen via standard venipuncture. Invert collection tube gently 8-10 times to ensure proper mixing with anticoagulant.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Frequently asked questions
What do the results mean?
Are there any risks associated with this test?
How often should this test be done?
What can affect my test results?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 10, 2026. · Read our editorial policy